Study Recruits Volunteers With or Without Neck Pain
Are you a healthy individual with neck pain for 3 months or less? If you are between ages 18 and 65, you may be able to participate in a neck pain study and receive a comprehensive cervical musculoskeletal examination. Healthy volunteers are also needed. Email NeckPainStudy@gmail.com or call (301) 451-7514 and mention protocol 02-CC-0245.
Study of Effects of Exercise on Cortisol
NICHD is looking for men ages 18-30 who run more than 28 miles a week or exercise for less than 1 hour a week. Participants will provide urine, saliva and blood samples as outpatients. Participants will take study medication on four afternoons and come for additional testing. Healthy normal weight men are encouraged to call 1-800-411-1222 (TTY 1-866-411-1010) and refer to study 11-CH-0078. Compensation is provided for a completed study.
Women’s Health Studies Seek Volunteers
Are you a woman in good health? Healthy women ages 18-65 are needed to participate in NIMH outpatient research studies on the relationships between sex hormones, stress and mood. A significant number of women have feelings of irritability, sadness or anxiety during a reproductive hormone change. If you are a woman who does not experience mood changes, call (301) 496-9576 (TTY 1-866-411-1010). Mention protocols 81-M-0126, 88-M-0131 and 03-M-0138. Compensation is provided.
Have Postpartum Depression?
If you suffered from postpartum depression (PPD) following the birth of any of your children, consider participating in this 8-month outpatient research study at the Clinical Center. The NIMH study is designed to examine the role of hormones in the onset of PPD. To participate, you must be between ages 18-50 with regular menstrual cycles and not taking any medications. Call (301) 496-9576 (TTY 1-866-411-1010) and mention protocol 95-M-0097. There is no cost to participate and compensation may be provided.
Women Needed for Study of Cortisol-Blocking Med
NICHD is looking for women ages 45 to 70 who have had menopause, are overweight, have abnormal glucose and triglyceride (form of “bad” cholesterol) levels and are not on any estrogen-containing hormone therapy. After an initial screening visit for general health assessment, participants will undergo treatment with a cortisol-blocking medication (mifepristone) or a non-active pill (placebo) for 7 days. Each participant will take both study agents with a gap of 6 to 8 weeks between the two. Testing before and after treatment with the study medications will include blood-drawing over 24 hours, urine collection, an intravenous glucose tolerance test and 1- to 2-day overnight inpatient stay. Compensation will be provided. For more information, call 1-800-411-1222 (TTY 1-866-411-1010) and refer to study 11-CH-0208.